diagnostics

Antibody-based diagnostics detect disease markers with accuracy. Biointron explains how these tools advance research and clinical decision-making.

A common theme emerging from recent antibody research is the development and validation of advanced diagnostic tools based on antibody detection. Multiple studies highlight the creation of novel biosensors and assays designed to enhance the sensitivity, specificity, and efficiency of detecting antibodies across various diseases.

Antibodies are versatile research tools. Biointron highlights their applications in diagnostics, validation, and experimental discovery across biotechnology.

VHH antibodies, also known as nanobodies, are single-domain antibodies that are derived from camelid heavy-chain antibodies. Due to their small size (~ 15 kDa) and diverse applications in bio-derived therapeutics, these antibodies have widespread attention in the research and development community, with some examples below from just this week!

Antibody diagnostics like ELISA and lateral flow assays are essential tools. Biointron showcases their role in reliable disease detection and rapid clinical decisions.

Understand antibody specificity and selectivity to improve research accuracy, and learn how high-affinity antibodies enhance target recognition while minimizing assay cross-reactivity.

Antibodies defend against disease and power modern biotech. Biointron shares ten fascinating facts that highlight their versatility and impact in research and therapy.

Western blotting is a cornerstone assay. Master sample prep, antibody validation, and detection strategies that deliver clean, trustworthy protein analysis.

Learn how antibodies enable protein–protein interaction research using immunofluorescence, immunoprecipitation and co-immunoprecipitation to study signaling pathways and complexes.

Stability makes or breaks biologics. Understand drivers of aggregation, fragmentation, and chemical change—and the formulation tactics that protect quality.